Members |
targetComponentId |
Mental &/or developmental handicap screen |
Screening for developmental disorder (procedure) |
Mental disorder - unspecified whether during pregnancy or the puerperium |
Mental disorders during pregnancy, childbirth and the puerperium |
Mental disorder during pregnancy, childbirth or the puerperium NOS |
Mental disorders during pregnancy, childbirth and the puerperium |
Mental handicap |
Intellectual disability |
Mental handicap (specialty) |
Intellectual disability specialty |
Mental handicap (specialty) |
Intellectual disability specialty |
handicap mental (spécialité) |
Intellectual disability specialty |
service de psychiatrie spécialisée dans le handicap mental |
Intellectual disability psychiatry department (environment) |
service de psychiatrie en déficience mentale |
Intellectual disability psychiatry service |
examen physique annuel en santé mentale effectué |
Annual physical examination for people with mental illness completed |
Mental health crisis plan |
Mental health crisis plan |
Mental health personal health plan |
Mental health personal health plan |
retard mental |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation NOS |
Intellectual disability |
Mental retardation screening |
Intellectual disability screening |
dépistage d'un handicap mental ou de développement |
Screening for developmental disorder (procedure) |
Mental/developmental handicap screening NOS |
Screening for developmental disorder (procedure) |
Mental/developmental handicap screening NOS |
Screening for developmental disorder (procedure) |
Menthol 35.55mg inhalant capsule |
Product containing only menthol in pulmonary dose form (medicinal product form) |
Mepacrine hydrochloride 100mg tablet |
Mepacrine hydrochloride 100 mg oral tablet |
Meperidine hydrochloride 100mg/mL injection solution ampule |
Product containing only pethidine in parenteral dose form (medicinal product form) |
Meperidine hydrochloride 50mg/5mL syrup |
Pethidine hydrochloride 10 mg/mL oral solution |
Meperidine hydrochloride 50mg/mL injection solution ampule |
Product containing only pethidine in parenteral dose form (medicinal product form) |
Meperidine hydrochloride 50mg/promethazine hydrochloride 50mg injection solution vial |
Product containing only pethidine and promethazine (medicinal product) |
Mepivacaine hydrochloride 3%/levonordefrin 1:20,000 injection solution vial |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
Mepivacaine hydrochloride 30mg/sodium chloride 3mg injection solution vial |
Mepivacaine only product |
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Meptazinol 100mg/1mL injection |
Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Meptazinol 100mg/mL injection solution 1mL ampule |
Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Meptazinol 200mg tablet |
Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet |
Mercurophylline injection |
Mercurophylline |
Merselene patch |
Polyester mesh (physical object) |
Mesalamine 250mg capsule |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalamine 250mg m/r capsule |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalamine 250mg prolonged-release oral capsule |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalamine 375mg m/r capsule |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalamine 375mg prolonged-release oral capsule |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalazine 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
Mesalazine 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
Mesalazine 2g/59mL enema |
Mesalazine only product in rectal dose form |
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalazine 500mg/sachet m/r granules |
Product containing only mesalazine in oral dose form (medicinal product form) |
Mesalazine duplicate deleted |
Product containing mesalazine (medicinal product) |
Mesenteric venous thrombosis |
Thrombosis of mesenteric vein |
Mesio-occlusion |
Mesio-occlusion of teeth |
Mesonephric tumor |
Wolffian tumor of uncertain behavior (morphologic abnormality) |
Mesoridazine besylate 10mg/mL injection solution ampule |
Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Mesoridazine besylate 25mg/mL injection solution ampule |
Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Mesothelioma, biphasic, benign |
Mesothelioma, benign |
Metabolic acidosis caused by ingestion of drugs AND/OR chemicals |
Metabolic acidosis |
Metabolic disease, NEC |
Metabolic disease |
Metabolic marker |
Inborn errors of metabolism marker |
Metaiodobenzylguanidine[123I] 74MBq/mL injection |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[123I] 74MBq/mL powder for injection solution vial |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[131I] 37MBq/mL injection |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[131I] 37MBq/mL powder for injection solution vial |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[131I]370MBq/mL injection |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[131I]37MBq/mL diagnostic injection |
Iobenguane (131-I)-containing product in parenteral dose form |
Metaiodobenzylguanidine[131I]9.25MBq/mL diagnostic injection |
Iobenguane (131-I)-containing product in parenteral dose form |
Metallocarboxypeptidase |
Metallocarboxypeptidase |
Metalloproteinase |
Metalloproteinase (substance) |
Metaproterenol 20mg tablet |
Orciprenaline sulfate 20 mg oral tablet |
Metaproterenol sulfate 0.65mg/inh aerosol |
Orciprenaline only product in pulmonary dose form |
Metaproterenol sulfate 15mg/mL aerosol |
Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Metastasis stage M1a |
American Joint Committee on Cancer cM1a (qualifier value) |
Metastasis stage M1b |
American Joint Committee on Cancer cM1b (qualifier value) |
Metastasis stage M1c |
cM1c |
Metastasis stage M2 |
American Joint Committee on Cancer cM1 (qualifier value) |
Metastasis stage M3 |
American Joint Committee on Cancer cM1 (qualifier value) |
Metastasis stage M4 |
American Joint Committee on Cancer cM1 (qualifier value) |
Metastasis stage pM1 |
American Joint Committee on Cancer pM1 (qualifier value) |
Metastasizing pleomorphic adenoma |
Pleomorphic adenoma |
Metatarsal phalangeal joint flap |
Flap (substance) |
Methacholine 2.5% eye drops |
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) |
Methacholine chloride 100mg powder |
Product containing only methacholine (medicinal product) |
Methadone 10mg/5mL mixture |
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
Methadone hydrochloride 40mg dispersible tablet |
Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Methamphetamine hydrochloride 10mg m/r tablet |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 10mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 15mg m/r tablet |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 15mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 5mg m/r tablet |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 5mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
Methods of operation NOC |
Surgical procedure (procedure) |
Methods of operation NOC NOS |
Surgical procedure (procedure) |
Methohexital sodium 5g powder for injection solution vial |
Product containing only methohexital (medicinal product) |
Methoxsalen 20mcg/mL injection solution 10mL vial |
Methoxsalen 20 microgram/mL solution for injection |
Methyl aminolevulinate 168mg/g topical cream |
Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream |
Methyl methacrylate embolism |
Foreign body embolus |
Methyl parathion |
Hexaethyl tetraphosphate |
Methylcellulose 1% eye drops |
Methylcellulose 10 mg/mL eye solution |
Methylene blue 1% injection solution vial |
Methylthioninium chloride only product in parenteral dose form |
Methylene blue 65mg tablet |
Methylthioninium chloride 65 mg oral tablet |
Methylenedioxymethamphetamine dependence with current use |
Methylenedioxymethamphetamine dependence |
Methylobacterium animovorans |
Methylorubrum aminovorans (organism) |
Methylobacterium lusitanum |
Methylorubrum rhodesianum (organism) |
Methylphenidate 10mg chewable tablet |
Methylphenidate hydrochloride 10 mg chewable tablet |
Methylphenidate 2.5mg chewable tablet |
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) |